Abstract
This article will address the general approach to management of the typical patient >75 years of age with atrial fibrillation. Emphasis will be placed on optimizing the benefit and reducing the risk of anticoagulation in this important and expanding group of patients.
MeSH terms
-
Aged
-
Anticoagulants / therapeutic use
-
Aspirin / therapeutic use
-
Atrial Fibrillation / complications*
-
Atrial Fibrillation / therapy*
-
Humans
-
Risk Assessment
-
Stroke / etiology*
-
Stroke / prevention & control
-
Warfarin / therapeutic use
Substances
-
Anticoagulants
-
Warfarin
-
Aspirin